(Q33921146)

30 July 2017

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy (English)

1 reference

30 July 2017

anti-retroviral agent

0 references

10

Robert F Siliciano

1 reference

30 July 2017

12

Joseph J Eron

1 reference

30 July 2017

11

Janet D Siliciano

1 reference

30 July 2017

7

Barbara Bastow

1 reference

30 July 2017

Rajesh T Gandhi

1

1 reference

30 July 2017

Ronald J Bosch

2

1 reference

30 July 2017

Evgenia Aga

3

1 reference

30 July 2017

Mary Albrecht

4

1 reference

30 July 2017

Lisa M Demeter

5

1 reference

30 July 2017

Carrie Dykes

6

1 reference

30 July 2017

Michael Para

8

1 reference

30 July 2017

Jun Lai

9

1 reference

30 July 2017

AIDS Clinical Trials Group A5173 Team

13

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Journal of Infectious Diseases

30 July 2017

1 reference

30 July 2017

201

1 reference

30 July 2017

2

1 reference

30 July 2017

293-296

1 reference

The challenge of finding a cure for HIV infection

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887684

29 October 2018

Identifiers

DOI

10.1086/649569

1 reference

30 July 2017

1 reference

30 July 2017

1 reference